Annual Operating Expenses
$244.12 M
+$36.04 M+17.32%
31 December 2023
Summary:
Kymera Therapeutics annual total operating expenses is currently $244.12 million, with the most recent change of +$36.04 million (+17.32%) on 31 December 2023. During the last 3 years, it has risen by +$163.78 million (+203.87%). KYMR annual operating expenses is now at all-time high.KYMR Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$75.86 M
-$710.00 K-0.93%
30 September 2024
Summary:
Kymera Therapeutics quarterly total operating expenses is currently $75.86 million, with the most recent change of -$710.00 thousand (-0.93%) on 30 September 2024. Over the past year, it has increased by +$13.63 million (+21.90%). KYMR quarterly operating expenses is now -0.93% below its all-time high of $76.58 million, reached on 30 June 2024.KYMR Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KYMR Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +17.3% | +21.9% |
| 3 y3 years | +203.9% | +54.9% |
| 5 y5 years | +1038.0% | +492.2% |
KYMR Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +203.9% | -0.9% | +63.0% |
| 5 y | 5 years | at high | +1038.0% | -0.9% | +492.2% |
| alltime | all time | at high | +1038.0% | -0.9% | +492.2% |
Kymera Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $75.86 M(-0.9%) |
| June 2024 | - | $76.58 M(+21.2%) |
| Mar 2024 | - | $63.19 M(-6.0%) |
| Dec 2023 | $244.12 M(+17.3%) | $67.20 M(+8.0%) |
| Sept 2023 | - | $62.24 M(+3.9%) |
| June 2023 | - | $59.90 M(+9.3%) |
| Mar 2023 | - | $54.79 M(+0.0%) |
| Dec 2022 | $208.08 M(+20.0%) | $54.77 M(+0.6%) |
| Sept 2022 | - | $54.43 M(+4.0%) |
| June 2022 | - | $52.32 M(+12.4%) |
| Mar 2022 | - | $46.55 M(-5.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $173.36 M(+115.8%) | $49.27 M(+0.6%) |
| Sept 2021 | - | $48.97 M(+13.2%) |
| June 2021 | - | $43.25 M(+35.7%) |
| Mar 2021 | - | $31.87 M(+24.7%) |
| Dec 2020 | $80.34 M(+78.0%) | $25.57 M(+13.0%) |
| Sept 2020 | - | $22.62 M(+29.4%) |
| June 2020 | - | $17.48 M(+19.1%) |
| Mar 2020 | - | $14.68 M(+7.8%) |
| Dec 2019 | $45.14 M(+110.4%) | $13.62 M(+6.3%) |
| Sept 2019 | - | $12.81 M |
| Dec 2018 | $21.45 M | - |
FAQ
- What is Kymera Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Kymera Therapeutics?
- What is Kymera Therapeutics annual operating expenses year-on-year change?
- What is Kymera Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Kymera Therapeutics?
- What is Kymera Therapeutics quarterly operating expenses year-on-year change?
What is Kymera Therapeutics annual total operating expenses?
The current annual operating expenses of KYMR is $244.12 M
What is the all time high annual operating expenses for Kymera Therapeutics?
Kymera Therapeutics all-time high annual total operating expenses is $244.12 M
What is Kymera Therapeutics annual operating expenses year-on-year change?
Over the past year, KYMR annual total operating expenses has changed by +$36.04 M (+17.32%)
What is Kymera Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of KYMR is $75.86 M
What is the all time high quarterly operating expenses for Kymera Therapeutics?
Kymera Therapeutics all-time high quarterly total operating expenses is $76.58 M
What is Kymera Therapeutics quarterly operating expenses year-on-year change?
Over the past year, KYMR quarterly total operating expenses has changed by +$13.63 M (+21.90%)